Stocktoria
Drugs Made In America Acquisition II Corp. DMII
Drugs Made In America Acquisition II Corp. (DMII) earns a Piotroski F-score of 1/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend.
How it ranks in Finance, Insurance & Real Estate · percentile among 1129 companies
Percentile vs other Finance, Insurance & Real Estate companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 1/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.001 |
| Retained earnings / assets | -0.035 |
| EBIT / assets | -0.001 |
| Equity / liabilities | -0.999 |
Sector peers · similar-size Finance, Insurance & Real Estate companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| DMII | Drugs Made In America Acquisition II Corp. | 1/9 | -1.17 | 152.9 | — |
| IPCX | Inflection Point Acquisition Corp. III | 3/9 | -1.27 | 713.8 | — |
| INV | Innventure, Inc. | 4/9 | -2.76 | — | — |
| INNI | Innovaro, Inc. | 1/9 | — | — | -96.4% |
| JFTH | Japan Food Tech Holdings, Inc. | 2/9 | — | — | — |
| MUFG | MITSUBISHI UFJ FINANCIAL GROUP INC | 4/9 | — | — | +9.5% |
| MFG | MIZUHO FINANCIAL GROUP INC | 4/9 | — | — | +7.6% |
All Finance, Insurance & Real Estate companies →
About Drugs Made In America Acquisition II Corp.
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
FAQ
Is DMII financially healthy?
Drugs Made In America Acquisition II Corp.'s Piotroski F-score is 1/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does DMII pay a dividend?
No, Drugs Made In America Acquisition II Corp. does not currently pay a dividend.
What is DMII's P/E ratio?
Drugs Made In America Acquisition II Corp.'s trailing price-to-earnings (P/E) ratio is about 152.9×, based on its latest annual earnings.
Is DMII a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Drugs Made In America Acquisition II Corp.: a Piotroski F-score of 1/9, an Altman Z″ in the distress zone, a P/E of about 152.9×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.